You just read:

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

News provided by

Bayer HealthCare

Aug 31, 2015, 11:30 ET